A recent study has also proposed the inclusion of TRBC1 in a panel for T-cell lymphoma screening, including CD45, CD4, CD2, CD5, TCRγδ, CD7, CD3 and TRBC1 [15]. This evidence concerns the gene CD4 and T-cell non-Hodgkin lymphoma.